Dr. Saini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2015 - 2018
- Salem HospitalResidency, Internal Medicine, 2011 - 2013
- Salem HospitalResidency, Internal Medicine, 2010 - 2013
- B. J. Medical College AhmedabadClass of 2007
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2022 - 2026
- GA State Medical License 2022 - 2026
- TN State Medical License 2022 - 2026
- AL State Medical License 2022 - 2025
- LA State Medical License 2022 - 2025
- MS State Medical License 2022 - 2025
- Join now to see all
Clinical Trials
- Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma Start of enrollment: 2023 Jan 05
Roles: Contact, Principal Investigator
- Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. Start of enrollment: 2024 Feb 19
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.Curtis Marcoux, Sarah Pasyar, Denái R Milton, Hina N Khan, Mark R Tanner
British Journal of Haematology. 2024-11-28 - Optimal infused CD34cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Babar Pal, Mark R Tanner
Blood Cancer Journal. 2024-10-31 - Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy.Rishika Prasad, Abdur Rehman, Lubna Rehman, Faezeh Darbaniyan, Viktoria Blumenberg
Blood. 2024-10-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: